Entry |
|
Name |
Ridogrel (USAN/INN) |
Formula |
C18H17F3N2O3
|
Exact mass |
366.1191
|
Mol weight |
366.3344
|
Structure |
|
Class |
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
Anti-allergic agent
DG01517 Thromboxane A2 receptor antagonist
|
Efficacy |
Antithrombotic, Thromboxane A2 (TXA2) receptor antagonist, Thromboxane synthetase inhibitor |
Target |
|
Pathway |
hsa04080 | Neuroactive ligand-receptor interaction |
|
Interaction |
|
Brite |
Drug groups [BR:br08330]
Blood modifier agent
DG01950 Antithrombotic agent
DG01712 Antiplatelet agent
DG01516 Thromboxane A2 synthase inhibitor
D05727 Ridogrel
Anti-allergic agent
DG01517 Thromboxane A2 receptor antagonist
D05727 Ridogrel
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Thromboxane
TBXA2R
D05727 Ridogrel (USAN/INN)
Enzymes
Isomerases (EC5)
Thromboxane-A synthase
TBXAS1 (CYP5A1)
D05727 Ridogrel (USAN/INN)
|
Other DBs |
|
KCF data |
ATOM 26
1 N5x N 28.4358 -35.0758
2 C8x C 28.4358 -36.4811
3 C8x C 29.6528 -37.1837
4 C8x C 30.8698 -36.4811
5 C8y C 30.8698 -35.0758
6 C8x C 29.6528 -34.3732
7 C8x C 33.3037 -36.4811
8 C8y C 33.3037 -35.0758
9 C2c C 32.0868 -34.3732
10 C8y C 34.5208 -37.1837
11 C8x C 35.7378 -36.4811
12 C8x C 35.7378 -35.0758
13 C8x C 34.5208 -34.3732
14 N2b N 32.0868 -32.9679
15 O2a O 33.3058 -32.2641
16 C1b C 34.5068 -32.9577
17 C1b C 35.6981 -32.2699
18 C1b C 36.8941 -32.9607
19 C1b C 38.0880 -32.2714
20 C6a C 39.2826 -32.9614
21 O6a O 40.4771 -32.2718
22 O6a O 39.2825 -34.3730
23 C1d C 34.5207 -38.5700
24 X F 33.1207 -38.5700
25 X F 35.9207 -38.5700
26 X F 34.5207 -39.9700
BOND 27
1 1 2 2
2 2 3 1
3 3 4 2
4 4 5 1
5 5 6 2
6 1 6 1
7 7 8 1
8 8 9 1
9 5 9 1
10 7 10 2
11 10 11 1
12 11 12 2
13 12 13 1
14 8 13 2
15 9 14 2
16 14 15 1
17 15 16 1
18 16 17 1
19 17 18 1
20 18 19 1
21 19 20 1
22 20 21 1
23 20 22 2
24 10 23 1
25 23 24 1
26 23 25 1
27 23 26 1
|